One promising tool is NAD (nicotinamide adenine dinucleotide), a coenzyme essential for cellular energy production
[6] [25] At levels only slightly below normal, deficiency can result in fatigue, headaches, feeling faint, rapid breathing, pale skin, numbness or tingling, poor appetite, heartburn, poor balance, difficulty walking, poor reflexes, blurred vision, memory problems, depression, irritability, inattention, cognitive decline, dementia, and even psychosis
Adinolfi S, Patinen T, Jawahar Deen A, Pitknen S, Hrknen J, Kansanen E, et al
Orforglipron es un agonista GLP-1 oral de molcula pequea en desarrollo que ha demostrado reducciones de peso del 9,6% con la dosis de 36 mg en pacientes con obesidad y diabetes tipo 2
Using physical tools, we develop a simple model